To further explore whether Ac2-26, an active N-terminal peptide of ANXA1, could prevent obesity by inhibiting adipogenesis, Ac2-26 was incubated with SVFs at 0.1 mg/mL. The gene discussed is ANXA1; the disease is obesity due to melanocortin 4 receptor deficiency.